These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 15922717

  • 1. The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity.
    Sen G, Flora M, Chattopadhyay G, Klinman DM, Lees A, Mond JJ, Snapper CM.
    Cell Immunol; 2004; 232(1-2):64-74. PubMed ID: 15922717
    [Abstract] [Full Text] [Related]

  • 2. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J, Weeratna RD, Jurk M, Davis HL, Schetter C, Wüllner M, Wader T, Liu M, Kritzler A, Krieg AM.
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
    Vollmer J, Weeratna RD, Jurk M, Samulowitz U, McCluskie MJ, Payette P, Davis HL, Schetter C, Krieg AM.
    Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
    [Abstract] [Full Text] [Related]

  • 5. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
    Kandimalla ER, Bhagat L, Li Y, Yu D, Wang D, Cong YP, Song SS, Tang JX, Sullivan T, Agrawal S.
    Proc Natl Acad Sci U S A; 2005 May 10; 102(19):6925-30. PubMed ID: 15860583
    [Abstract] [Full Text] [Related]

  • 6. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
    Putta MR, Zhu F, Li Y, Bhagat L, Cong Y, Kandimalla ER, Agrawal S.
    Nucleic Acids Res; 2006 May 10; 34(11):3231-8. PubMed ID: 16798912
    [Abstract] [Full Text] [Related]

  • 7. A Toll-like receptor recognizes bacterial DNA.
    Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S.
    Nature; 2000 Dec 07; 408(6813):740-5. PubMed ID: 11130078
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Non-CpG-containing antisense 2'-methoxyethyl oligonucleotides activate a proinflammatory response independent of Toll-like receptor 9 or myeloid differentiation factor 88.
    Senn JJ, Burel S, Henry SP.
    J Pharmacol Exp Ther; 2005 Sep 07; 314(3):972-9. PubMed ID: 15919763
    [Abstract] [Full Text] [Related]

  • 10. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.
    Ballas ZK, Rasmussen WL, Krieg AM.
    J Immunol; 1996 Sep 01; 157(5):1840-5. PubMed ID: 8757300
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Toll-like receptor 9 mediates CpG-DNA signaling.
    Chuang TH, Lee J, Kline L, Mathison JC, Ulevitch RJ.
    J Leukoc Biol; 2002 Mar 01; 71(3):538-44. PubMed ID: 11867692
    [Abstract] [Full Text] [Related]

  • 13. Augmentation of T(H)-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling.
    Shimosato T, Kitazawa H, Katoh S, Tohno M, Iliev ID, Nagasawa C, Kimura T, Kawai Y, Saito T.
    Biochem Biophys Res Commun; 2005 Jan 28; 326(4):782-7. PubMed ID: 15607737
    [Abstract] [Full Text] [Related]

  • 14. Modifications incorporated in CpG motifs of oligodeoxynucleotides lead to antagonist activity of toll-like receptors 7 and 9.
    Yu D, Wang D, Zhu FG, Bhagat L, Dai M, Kandimalla ER, Agrawal S.
    J Med Chem; 2009 Aug 27; 52(16):5108-14. PubMed ID: 19650625
    [Abstract] [Full Text] [Related]

  • 15. Peptide conjugation at the 5'-end of oligodeoxynucleotides abrogates toll-like receptor 9-mediated immune stimulatory activity.
    Putta MR, Zhu FG, Wang D, Bhagat L, Dai M, Kandimalla ER, Agrawal S.
    Bioconjug Chem; 2010 Jan 27; 21(1):39-45. PubMed ID: 20020767
    [Abstract] [Full Text] [Related]

  • 16. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.
    Bauer S, Kirschning CJ, Häcker H, Redecke V, Hausmann S, Akira S, Wagner H, Lipford GB.
    Proc Natl Acad Sci U S A; 2001 Jul 31; 98(16):9237-42. PubMed ID: 11470918
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant properties of CpG oligonucleotides in primates.
    Verthelyi D.
    Methods Mol Med; 2006 Jul 31; 127():139-58. PubMed ID: 16988453
    [Abstract] [Full Text] [Related]

  • 18. Synergy of CpG oligodeoxynucleotide and double-stranded RNA (poly I:C) on nitric oxide induction in chicken peripheral blood monocytes.
    He H, Genovese KJ, Nisbet DJ, Kogut MH.
    Mol Immunol; 2007 May 31; 44(12):3234-42. PubMed ID: 17339052
    [Abstract] [Full Text] [Related]

  • 19. Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumors.
    Daftarian P, Song GY, Ali S, Faynsod M, Longmate J, Diamond DJ, Ellenhorn JD.
    Cancer Res; 2004 Aug 01; 64(15):5407-14. PubMed ID: 15289349
    [Abstract] [Full Text] [Related]

  • 20. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM, Al-Khairy D, Ingalls RR.
    Biol Reprod; 2006 May 01; 74(5):824-31. PubMed ID: 16421230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.